4//SEC Filing
Snisarenko John 4
Accession 0001209191-20-046095
CIK 0001720725other
Filed
Aug 10, 8:00 PM ET
Accepted
Aug 11, 4:03 PM ET
Size
8.2 KB
Accession
0001209191-20-046095
Insider Transaction Report
Form 4
Snisarenko John
Chief Commercial Officer
Transactions
- Purchase
Common Stock
2020-08-10$25.97/sh+4,000$103,880→ 7,000 total
Issuer
Oyster Point Pharma, Inc.
CIK 0001720725
Entity typeother
Related Parties
1- filerCIK 0001783264
Filing Metadata
- Form type
- 4
- Filed
- Aug 10, 8:00 PM ET
- Accepted
- Aug 11, 4:03 PM ET
- Size
- 8.2 KB